Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Figure 2

C-kit-immunohistochemistry. Expression of CD117 in gastric cancer specimens: Intestinal type (a, b-arrowhead) and diffuse type (d) gastric cancer specimens enclosed CD117-immunoreactive mast cells. Occasionally was CD117 expressed by tumor cells (b) and stromal cells (c-arrowhead). Anti-CD117, hematoxylin counterstain; Original magnifications: x400.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us